Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
REVIEW ARTICLE
Year : 2015  |  Volume : 28  |  Issue : 2  |  Page : 295-307

Subclinical endocrine disorders: a brief overview of risks, diagnosis, and workup of these disorders


1 Department of Internal Medicine, Faculty of Medicine, Menoufiya University, Menoufiya, Egypt
2 Department of Internal Medicine, Al Shouhadaa Hospital, Menoufiya, Egypt

Correspondence Address:
Ibrahim S Attiya
Al Shouhadaa Hospital, Menoufiya 32511
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1110-2098.163871

Rights and Permissions

Introduction Subclinical endocrine disorders are entities of mild degrees of endocrine dysfunction with no recognizable clinical findings. Objectives To shed light on up-to-date information on subclinical endocrine disorders and provide a brief overview of the risks, diagnosis, and workup of these disorders. Materials and methods We searched reference electronic databases, especially ScienceDirect, The Lancet, and Medscape, in the title of the article with the key words mentioned; extraction was carried out, including assessment of the quality and the validity of papers. Studies on subclinical disorders of each gland were collected; each study was reviewed independently. The data obtained were rebuilt in new language and divided into topics throughout the article. Recent findings There is strong evidence supporting the evolution of subclinical entities of various endocrine disorders. Some of these entities may behave as clinical ones, with possible adverse effects on body systems; thus, some symptoms may manifest soon, whereas others may be discovered accidently during routine laboratory and radiological investigations and they require careful periodic follow-up. Conclusion Subclinical hypothyroidism and subclinical Cushing's syndrome are well-known disorders. There have been advancements in early detection using screening programs and cases of these disorders. There is also evidence supporting their negative impact on cardiovascular morbidity and quality of life. Large-scale randomized-controlled trials are needed to inform how to best care for these and to gain more knowledge of these disorders.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2208    
    Printed13    
    Emailed0    
    PDF Downloaded176    
    Comments [Add]    

Recommend this journal